Comparison of Availability of Trial Results in ClinicalTrials.gov and PubMed by Data Source and Funder Type-Reference-Cited by-同舟云学术

Comparison of Availability of Trial Results in ClinicalTrials.gov and PubMed by Data Source and Funder Type

Published:2023-04-25 Issue:16 Volume:329 Page:1404
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Nelson Julianne T.¹,Tse Tony¹,Puplampu-Dove Yvonne¹,Golfinopoulos Elisa¹,Zarin Deborah A.²

Affiliation:

1. National Library of Medicine, National Institutes of Health, Bethesda, Maryland

2. Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard, Cambridge, Massachusetts

Abstract

This study examines the dissemination of trial results by data source (ie, ClinicalTrials.gov and PubMed) and funder type (ie, industry and nonindustry).

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2803167/jama_nelson_2023_ld_230018_1681934435.24975.pdf

Reference6 articles.

1. Medicine: moving toward transparency of clinical trials.;Zarin;Science,2008

2. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis.;Ross;BMJ,2012

3. Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals.;Riveros;PLoS Med,2013

4. Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005.;Zwierzyna;BMJ,2018

5. 10-Year update on study results submitted to ClinicalTrials.gov.;Zarin;N Engl J Med,2019

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Principal Features of Industry-Funded Trials that Posted Informed Consent Forms on ClinicalTrials.gov: a Cross-Sectional Analysis;The AAPS Journal;2024-06-18

2. Adequate information about clinical trial results must be given to participants;Nature Medicine;2024-05-08

3. Is full transparency in clinical trials an achievable goal?;European Journal of Internal Medicine;2024-05

4. Major UK non-commercial sponsors’ efforts to reduce research waste: a mixed-methods study;BMJ Evidence-Based Medicine;2024-04-17

5. Publication status and disclosure gaps in a cohort of 71 clinical trials assessing the safety and efficacy of 3 COVID-19 vaccines developed by Chinese biopharmaceutical companies: An observational cohort study;2024-03-18